In part 2 of this 2-part interview, Jason Bock, founder and CEO of CTMC provides input on how the FDA's proposed manufacturing registration rule may impact personalized therapies.
Jason Bock
Advertisement
Jason Bock is founder and CEO of CTMC.
Articles by Jason Bock
Jason Bock, founder and CEO of CTMC, provides his perspective on the FDA’s proposed rule to streamline registration for single distributed manufacturing establishments, and what the change may mean for personalized medicines.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
2
PharmSci 360: Build the Device Into Dosage Form Development From Day One
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
5